As the weather grows colder, many people are starting to plan their 2016 vacations. Among the TSA screenings and hotel ratings, there is one rarely discussed aspect of travel planning and safety: sexual health.
Research has shown that many men who have sex with men (MSM) have periods of elevated HIV risk that often coincide with times away from home or vacations. The often casual and spontaneous nature of sexual encounters while traveling can result in unprotected sex and, in doing so, raise one’s risk of HIV infection. Pre-exposure prophylaxis (PrEP), a daily pill to prevent HIV infection, is a powerful and proven tool in the fight against HIV. But does PrEP retain its effectiveness when it’s only used for a short time period – say, for the length of a vacation?
The Fenway Institute is looking into this question through the Vacation Study, which will examine the feasibility and acceptability of shorter-term PrEP use. By joining The Vacation Study, you may receive PrEP for the duration of your upcoming vacation, plus an additional two weeks. You may be eligible to participant in this study if you are an HIV-negative gay or bisexual male age 18 or older, are planning to take a vacation in the next few months, and have had unprotected anal sex in the last year.
Participants are compensated up to $100 over the course of the study.
For more information and to see if you are eligible, please call 617.927.6384 or email email@example.com.
Want to receive email updates about what’s happening at Fenway Health? Sign up here.